165 related articles for article (PubMed ID: 25880340)
1. Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex.
Sugiura H; Yasuda S; Katsurabayashi S; Kawano H; Endo K; Takasaki K; Iwasaki K; Ichikawa M; Kobayashi T; Hino O; Yamagata K
Nat Commun; 2015 Apr; 6():6842. PubMed ID: 25880340
[TBL] [Abstract][Full Text] [Related]
2. Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex.
Yasuda S; Sugiura H; Katsurabayashi S; Shimada T; Tanaka H; Takasaki K; Iwasaki K; Kobayashi T; Hino O; Yamagata K
Sci Rep; 2014 Jun; 4():5155. PubMed ID: 24889507
[TBL] [Abstract][Full Text] [Related]
3. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Tavazoie SF; Alvarez VA; Ridenour DA; Kwiatkowski DJ; Sabatini BL
Nat Neurosci; 2005 Dec; 8(12):1727-34. PubMed ID: 16286931
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.
Neuman NA; Henske EP
EMBO Mol Med; 2011 Apr; 3(4):189-200. PubMed ID: 21412983
[TBL] [Abstract][Full Text] [Related]
5. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity.
Finlay GA; Malhowski AJ; Liu Y; Fanburg BL; Kwiatkowski DJ; Toksoz D
Cancer Res; 2007 Oct; 67(20):9878-86. PubMed ID: 17942919
[TBL] [Abstract][Full Text] [Related]
7. Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis.
Lacher MD; Pincheira R; Zhu Z; Camoretti-Mercado B; Matli M; Warren RS; Castro AF
Oncogene; 2010 Dec; 29(50):6543-56. PubMed ID: 20818424
[TBL] [Abstract][Full Text] [Related]
8. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
Zhang Y; Gao X; Saucedo LJ; Ru B; Edgar BA; Pan D
Nat Cell Biol; 2003 Jun; 5(6):578-81. PubMed ID: 12771962
[TBL] [Abstract][Full Text] [Related]
9. A dual shaping mechanism for postsynaptic ephrin-B3 as a receptor that sculpts dendrites and synapses.
Xu NJ; Sun S; Gibson JR; Henkemeyer M
Nat Neurosci; 2011 Oct; 14(11):1421-9. PubMed ID: 21964490
[TBL] [Abstract][Full Text] [Related]
10. Rheb fills a GAP between TSC and TOR.
Manning BD; Cantley LC
Trends Biochem Sci; 2003 Nov; 28(11):573-6. PubMed ID: 14607085
[TBL] [Abstract][Full Text] [Related]
11. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase.
Hsu YC; Chern JJ; Cai Y; Liu M; Choi KW
Nature; 2007 Feb; 445(7129):785-8. PubMed ID: 17301792
[TBL] [Abstract][Full Text] [Related]
12. Measurements of TSC2 GAP activity toward Rheb.
Li Y; Inoki K; Vikis H; Guan KL
Methods Enzymol; 2006; 407():46-54. PubMed ID: 16757313
[TBL] [Abstract][Full Text] [Related]
13. Spine morphogenesis and synapse formation in tubular sclerosis complex models.
Shimada T; Yamagata K
Front Mol Neurosci; 2022; 15():1019343. PubMed ID: 36606143
[TBL] [Abstract][Full Text] [Related]
14. Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
Makovski V; Haklai R; Kloog Y
Int J Cancer; 2012 Mar; 130(6):1420-9. PubMed ID: 21500191
[TBL] [Abstract][Full Text] [Related]
15. A Farnesyltransferase Inhibitor Restores Cognitive Deficits in
Sugiura H; Shimada T; Moriya-Ito K; Goto JI; Fujiwara H; Ishii R; Shitara H; Taya C; Fujii S; Kobayashi T; Hino O; Worley PF; Yamagata K
J Neurosci; 2022 Mar; 42(12):2598-2612. PubMed ID: 35121635
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.
Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis complex: from Drosophila to human disease.
Pan D; Dong J; Zhang Y; Gao X
Trends Cell Biol; 2004 Feb; 14(2):78-85. PubMed ID: 15102439
[TBL] [Abstract][Full Text] [Related]
19. Rheb binds and regulates the mTOR kinase.
Long X; Lin Y; Ortiz-Vega S; Yonezawa K; Avruch J
Curr Biol; 2005 Apr; 15(8):702-13. PubMed ID: 15854902
[TBL] [Abstract][Full Text] [Related]
20. The small GTPase Rheb affects central brain neuronal morphology and memory formation in Drosophila.
Brown HL; Kaun KR; Edgar BA
PLoS One; 2012; 7(9):e44888. PubMed ID: 23028662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
